Patents by Inventor Mohamed A. Gaballa

Mohamed A. Gaballa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9687512
    Abstract: The present invention relates to isolated populations of cardiac stem cells. The invention provides methods for characterizing, isolating, and culturing cardiac stem cells from human tissue samples. The invention also provides compositions and methods useful for treating cardiac disease.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: June 27, 2017
    Assignee: Banner Health
    Inventor: Mohamed A. Gaballa
  • Patent number: 9636747
    Abstract: The functionalized silica for the synthesis of metal nanoparticles includes a silica surface functionalized by a hydrazino-triazine derivative. A method of preparing the functionalized silica includes the steps of combining silica gel and a triazine derivative in a first organic solvent to form a mixture; heating the mixture for about two hours; isolating a white solid by filtration; washing the solid with the first organic solvent; suspending the white solid in a second organic solvent to form a suspension; adding hydrazine hydrate to the suspension while stirring; heating the suspension for about 3 hours to form the silica surface functionalized by a hydrazino-triazine derivative; and isolating the silica surface functionalized by a hydrazino-triazine derivative by filtration.
    Type: Grant
    Filed: May 3, 2016
    Date of Patent: May 2, 2017
    Assignee: KING SAUD UNIVERSITY
    Inventors: Ayman Sadek Ahmed El-Faham, Moustafa Mohamed Gaballa El-Sayed Fouda, Zeid Abdullah Mohammad Al Othman
  • Patent number: 9562151
    Abstract: The present invention relates to a composition comprising nanoparticles stabilized by an at least partially deprotonated biopolymer and a method for the preparation thereof.
    Type: Grant
    Filed: December 3, 2012
    Date of Patent: February 7, 2017
    Assignee: King Saud University
    Inventors: Moustafa Mohamed Gaballa El-Sayed Fouda, Mehrez El-Sayed El-Naggar, Tharwat Ibrahim Shaheen, Salem S. Al Deyab
  • Publication number: 20150272999
    Abstract: The present invention relates to the delivery of stem cells to heart tissue by retrograde coronary vein infusion. The invention also provides methods useful for treating subjects with heart disease.
    Type: Application
    Filed: March 31, 2015
    Publication date: October 1, 2015
    Inventor: Mohamed A Gaballa
  • Publication number: 20150258147
    Abstract: The present invention relates to isolated populations of cardiac stem cells. The invention provides methods for characterizing, isolating, and culturing cardiac stem cells from human tissue samples. The invention also provides compositions and methods useful for treating cardiac disease.
    Type: Application
    Filed: March 12, 2015
    Publication date: September 17, 2015
    Inventor: Mohamed A. Gaballa
  • Publication number: 20150258084
    Abstract: The present invention relates to admixtures of stem cells and TGF-? inhibitors. The invention provides methods for characterizing, isolating, and culturing stem cells from human tissue samples. The invention also provides compositions and methods useful for treating subjects with disease (e.g. heart disease).
    Type: Application
    Filed: March 12, 2015
    Publication date: September 17, 2015
    Inventor: Mohamed A. Gaballa